(Q35111825)

English

Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Xiong YQ

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Potel G

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Caillon J

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Stephant G

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jehl F

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bugnon D

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Le Conte P

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Baron D

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Drugeon H

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 February 1995

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

496-499

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Experimental endocarditis: a review of its relevance to human endocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Determination of fosfomycin in biological fluids by capillary electrophoresis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

In vitro activity of ciprofloxacin against aerobic gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Pseudomonas aeruginosa endocarditis in drug addicts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Synergy of ciprofloxacin with fosfomycin in vitro against Pseudomonas isolates from patients with cystic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Synergy of fluoroquinolones with other antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

In vivo antibiotic synergism: contribution of animal models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=162566

9 July 2018

Treatment of patients with pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7726520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/7726520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method

1 reference

https://pubmed.ncbi.nlm.nih.gov/7726520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of the pre-treatment interval on antimicrobial efficacy in a biological model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7726520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7726520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.39.2.496

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35111825&oldid=1794535855"